These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 18695273)
1. Empiric antibiotic therapy in children with community-acquired pneumonia. Zhang L; Lovatel R; Nicolete D; Sinzkel E; Matiello J; Staszko K; Lincho C Indian Pediatr; 2008 Jul; 45(7):554-8. PubMed ID: 18695273 [TBL] [Abstract][Full Text] [Related]
2. Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia. Ambroggio L; Taylor JA; Tabb LP; Newschaffer CJ; Evans AA; Shah SS J Pediatr; 2012 Dec; 161(6):1097-103. PubMed ID: 22901738 [TBL] [Abstract][Full Text] [Related]
3. [Antibiotic therapy in community acquired pneumonia in children]. Kulus M Pol Merkur Lekarski; 2011 May; 30(179):346-8. PubMed ID: 21675139 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime. Dinur-Schejter Y; Cohen-Cymberknoh M; Tenenbaum A; Brooks R; Averbuch D; Kharasch S; Kerem E Pediatr Pulmonol; 2013 Jan; 48(1):52-8. PubMed ID: 22431471 [TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of empiric antibiotics for community-acquired pneumonia. Queen MA; Myers AL; Hall M; Shah SS; Williams DJ; Auger KA; Jerardi KE; Statile AM; Tieder JS Pediatrics; 2014 Jan; 133(1):e23-9. PubMed ID: 24324001 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis. Marras TK; Nopmaneejumruslers C; Chan CK Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587 [TBL] [Abstract][Full Text] [Related]
8. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops. Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560 [TBL] [Abstract][Full Text] [Related]
9. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital. Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB; Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688 [TBL] [Abstract][Full Text] [Related]
10. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment. Marcus N; Ashkenazi S; Samra Z; Cohen A; Livni G Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227 [TBL] [Abstract][Full Text] [Related]
11. Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study. Egelund GB; Jensen AV; Andersen SB; Petersen PT; Lindhardt BØ; von Plessen C; Rohde G; Ravn P BMC Pulm Med; 2017 Apr; 17(1):66. PubMed ID: 28427381 [TBL] [Abstract][Full Text] [Related]
12. Poor adherence to South African guidelines for the management of community-acquired pneumonia. Nyamande K; Lalloo UG S Afr Med J; 2007 Aug; 97(8):601-3. PubMed ID: 17952218 [TBL] [Abstract][Full Text] [Related]
13. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. Feagan BG; Marrie TJ; Lau CY; Wheeler SL; Wong CJ; Vandervoort MK CMAJ; 2000 May; 162(10):1415-20. PubMed ID: 10834044 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic utilization and cost analysis in hospitalized patients with community-acquired pneumonia. Stein GE; Mantz SL Hosp Pharm; 1995 Feb; 30(2):132-4, 137. PubMed ID: 10140526 [TBL] [Abstract][Full Text] [Related]
15. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787 [TBL] [Abstract][Full Text] [Related]
16. Impact of a guideline on management of children hospitalized with community-acquired pneumonia. Newman RE; Hedican EB; Herigon JC; Williams DD; Williams AR; Newland JG Pediatrics; 2012 Mar; 129(3):e597-604. PubMed ID: 22351891 [TBL] [Abstract][Full Text] [Related]
17. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492 [TBL] [Abstract][Full Text] [Related]
18. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069 [TBL] [Abstract][Full Text] [Related]
19. Impact of postgraduate education on physician practice for community-acquired pneumonia. Ikai H; Morimoto T; Shimbo T; Imanaka Y; Koike K J Eval Clin Pract; 2012 Apr; 18(2):389-95. PubMed ID: 21208347 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home. Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]